Shopping for U.S. auto insurance remained in high gear through the fourth quarter of 2025, according to the latest U.S. Insurance Demand Meter from LexisNexis® Risk Solutions. The quarterly ...
The banking regulator recently released draft guidelines that seek to make banks more accountable for the financial products they sell. If it follows through on this, it could dampen growth in the ...
Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...
Datasurance integration helps protect clients against the £14.7 billion annual cyber threat cost to UK businesses, ...
US auto insurance shopping and new business growth closed out 2025 at record levels, as consumers remained highly active in the fourth quarter. That is according to the latest LexisNexis® US Insurance ...
Universal Insurance Holdings (NYSE: UVE) ("Universal" or the "Company") reported fourth quarter and full year 2025 resul ...
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices ...
Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price. | ...
It is projected to post a 9.7% CAGR from 2024 to 2030. Singapore’s life and non-life insurance market is projected to reach ...
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% ...
As registrations for the 2026 Unified Tertiary Matriculation Examination (UTME) and Direct Entry examinations continue across ...